Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Clin Infect Dis
    September 2021
  1. OHM M, Hahne SJM, van der Ende A, Sanders EAM, et al
    Vaccine impact and effectiveness of meningococcal serogroup ACWY conjugate vaccine implementation in the Netherlands: a nationwide surveillance study.
    Clin Infect Dis. 2021 Sep 15. pii: 6370762. doi: 10.1093.
    >> Share

  2. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  3. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
    Clin Infect Dis. 2021;73:935-936.
    >> Share

  4. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  5. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  6. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  7. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  8. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  9. YILDIRIM I, Kao CM, Tippett A, Suntarattiwong P, et al
    A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.
    Clin Infect Dis. 2021 Aug 19. pii: 6354891. doi: 10.1093.
    >> Share

  10. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  11. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  12. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  13. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  14. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

    July 2021
  15. GHAMANDE S, Shaver C, Murthy K, Raiyani C, et al
    Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Clin Infect Dis. 2021 Jul 28. pii: 6329674. doi: 10.1093.
    >> Share

  16. BOLLAERTS K, Fletcher MA, Suaya JA, Hanquet G, et al
    Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.
    Clin Infect Dis. 2021 Jul 27. pii: 6329127. doi: 10.1093.
    >> Share

  17. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    >> Share

  18. NAUCLER P, Galanis I, Petropoulos A, Granath F, et al
    Chronic disease and immunosuppression increase the risk for non-vaccine serotype pneumococcal disease - a nationwide population-based study.
    Clin Infect Dis. 2021 Jul 24. pii: 6327794. doi: 10.1093.
    >> Share

  19. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    >> Share

  20. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    >> Share

  21. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    >> Share

  22. BOUTRY C, Hastie A, Diez-Domingo J, Tinoco JC, et al
    The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).
    Clin Infect Dis. 2021 Jul 20. pii: 6324611. doi: 10.1093.
    >> Share

  23. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    >> Share

  24. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    >> Share

  25. TOTA JE, Giuliano AR, Goldstone SE, Dubin B, et al
    Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2021 Jul 15. pii: 6321740. doi: 10.1093.
    >> Share

  26. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    >> Share

  27. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    >> Share

  28. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    >> Share

  29. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    >> Share

  30. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    >> Share

  31. BERENSON AB, Hirth JM, Chang M
    Prevalence of oral human papillomavirus infection: Impact of sex, race/ethnicity and vaccination status.
    Clin Infect Dis. 2021 Jul 4. pii: 6314534. doi: 10.1093.
    >> Share

  32. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    >> Share

    June 2021
  33. ANDREJKO K, Whittles LK, Lewnard JA
    Health-economic value of vaccination against group A Streptococcus in the United States.
    Clin Infect Dis. 2021 Jun 30. pii: 6311854. doi: 10.1093.
    >> Share

  34. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    >> Share

  35. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    >> Share

  36. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    >> Share

  37. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    >> Share

  38. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    >> Share

  39. METCALF BJ, Chochua S, Walker H, Tran T, et al
    Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
    Clin Infect Dis. 2021;72:e948-e956.
    >> Share

  40. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    >> Share

  41. CURREN EJ, Shankar MB, Fischer M, Meltzer MI, et al
    Cost effectiveness and impact of a targeted age- and incidence-based West Nile virus vaccine strategy.
    Clin Infect Dis. 2021 Jun 12. pii: 6297173. doi: 10.1093.
    >> Share

  42. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    >> Share

  43. MWENDA JM, Hallowell BD, Parashar U, Shaba K, et al
    Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018.
    Clin Infect Dis. 2021 Jun 5. pii: 6293961. doi: 10.1093.
    >> Share

  44. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    >> Share

  45. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    >> Share

  46. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    >> Share

  47. WYLLIE AL, Warren JL, Regev-Yochay G, Givon-Lavi N, et al
    Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children.
    Clin Infect Dis. 2021;72:e768-e775.
    >> Share

  48. AFRICANO HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, Bustos IG, et al
    Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.
    Clin Infect Dis. 2021;72:e711-e719.
    >> Share

    May 2021
  49. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    >> Share

  50. GOWER CM, Stowe J, Andrews NJ, Dunning J, et al
    Sustained declines in age group-specific rotavirus infection and acute gastroenteritis in vaccinated and unvaccinated individuals during the five years since Rotavirus vaccine introduction in England.
    Clin Infect Dis. 2021 May 27. pii: 6287118. doi: 10.1093.
    >> Share

  51. NEWALL AT, Leong RN, Reyes JF, Curns AT, et al
    Rotavirus vaccination likely to be cost saving to society in the United States.
    Clin Infect Dis. 2021 May 26. pii: 6285405. doi: 10.1093.
    >> Share

  52. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    >> Share

  53. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    >> Share

  54. GRIJALVA CG, Feldstein LR, Talbot HK, Aboodi M, et al
    Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.
    Clin Infect Dis. 2021 May 20. pii: 6279050. doi: 10.1093.
    >> Share

  55. DANINO D, Van Der Beek BA, Givon-Lavi N, Greenberg D, et al
    Unravelling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2021 May 20. pii: 6278471. doi: 10.1093.
    >> Share

  56. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
    >> Share

  57. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    >> Share

  58. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    >> Share

  59. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    >> Share

  60. PALEFSKY JM, Lensing SY, Belzer M, Lee J, et al
    High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with HIV.
    Clin Infect Dis. 2021 May 15. pii: 6276233. doi: 10.1093.
    >> Share

  61. VANIJCHAROENKARN K, Lee FE, Martin L, Shih J, et al
    Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.
    Clin Infect Dis. 2021 May 14. pii: 6275836. doi: 10.1093.
    >> Share

  62. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    >> Share

  63. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    >> Share

  64. YADAV PD, Sapkal GN, Abraham P, Ella R, et al
    Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees.
    Clin Infect Dis. 2021 May 7. pii: 6271524. doi: 10.1093.
    >> Share

  65. MALOSH RE, Petrie JG, Callear A, Truscon R, et al
    Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection?
    Clin Infect Dis. 2021 May 5. pii: 6265275. doi: 10.1093.
    >> Share

  66. ORTIZ JR, Yu SL, Driscoll AJ, Williams SR, et al
    The operational feasibility of vaccination programs targeting influenza risk groups in the WHO African and South-East Asian Regions.
    Clin Infect Dis. 2021 May 5. pii: 6265274. doi: 10.1093.
    >> Share

  67. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    >> Share

  68. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    >> Share

  69. BENET T, Amour S, Valette M, Saadatian-Elahi M, et al
    Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2021;72:e311-e318.
    >> Share

  70. SALAMA M, Indenbaum V, Nuss N, Savion M, et al
    A Measles Outbreak in the Tel Aviv District, Israel, 2018-2019.
    Clin Infect Dis. 2021;72:1649-1656.
    >> Share

    April 2021
  71. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    >> Share

  72. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    >> Share

  73. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    >> Share

  74. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    >> Share

  75. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    >> Share

  76. COHEN R, Levy C, Ouldali N, Goldrey M, et al
    Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation.
    Clin Infect Dis. 2021;72:1453-1456.
    >> Share

  77. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    >> Share

  78. RANE MS, Halloran ME
    Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data.
    Clin Infect Dis. 2021 Apr 21. pii: 6243988. doi: 10.1093.
    >> Share

  79. DAGAN R, Ben-Shimol S, Greenberg D, Givon-Lavi N, et al
    A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
    Clin Infect Dis. 2021;72:1200-1207.
    >> Share

  80. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    >> Share

  81. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    >> Share

  82. FORRAT R, Dayan GH, DiazGranados CA, Bonaparte M, et al
    Analysis of hospitalized and severe dengue cases over the six-years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America.
    Clin Infect Dis. 2021 Apr 4. pii: 6210060. doi: 10.1093.
    >> Share

  83. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    >> Share

    March 2021
  84. HALSTEAD SB
    Is Dengue Vaccine Protection Possible?
    Clin Infect Dis. 2021 Mar 31. pii: 6206739. doi: 10.1093.
    >> Share

  85. KISSLER SM, Mitchell M, Grad YH
    Reduction in antibiotic prescribing attainable with a gonococcal vaccine.
    Clin Infect Dis. 2021 Mar 31. pii: 6205093. doi: 10.1093.
    >> Share

  86. BODDINGTON NL, Pearson I, Whitaker H, Mangtani P, et al
    Effectiveness of influenza vaccination in preventing hospitalisation due to influenza in children: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Mar 27. pii: 6193428. doi: 10.1093.
    >> Share

  87. ORIJE MRP, Lariviere Y, Herzog SA, Mahieu LM, et al
    Breast milk antibody levels in Tdap vaccinated women after preterm delivery.
    Clin Infect Dis. 2021 Mar 26. pii: 6188768. doi: 10.1093.
    >> Share

  88. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    >> Share

  89. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    >> Share

  90. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    >> Share

  91. CZAJA CA, Cockburn MG, Colborn K, Miller L, et al
    Adult population coverage with influenza vaccine and influenza hospitalization rates-is there a role for active outreach to immunize at-risk neighborhoods?
    Clin Infect Dis. 2021 Mar 14. pii: 6170704. doi: 10.1093.
    >> Share

  92. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    >> Share

  93. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    >> Share

  94. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    >> Share

  95. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    >> Share

    February 2021
  96. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    >> Share

  97. MEITES E, Stone L, Amiling R, Singh V, et al
    Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following HPV Vaccine Introduction in the United States.
    Clin Infect Dis. 2021 Feb 23. pii: 6148742. doi: 10.1093.
    >> Share

  98. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-Derived Quadrivalent Inactivated Influenza Vaccines and High-Dose Trivalent Influenza Vaccine in Preventing Influenza-Related Medical Encounters in US Adults >/=65
    Clin Infect Dis. 2021 Feb 19. pii: 6144977. doi: 10.1093.
    >> Share

  99. MCMILLAN M, Wang B, Koehler AP, Sullivan TR, et al
    Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.
    Clin Infect Dis. 2021 Feb 15. pii: 6136296. doi: 10.1093/cid/ciaa1636.
    >> Share

  100. SUN Y, Kim E, Kong CL, Arnold BF, et al
    Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study.
    Clin Infect Dis. 2021 Feb 13. pii: 6134288. doi: 10.1093.
    >> Share

  101. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    >> Share

  102. IZURIETA HS, Wu X, Forshee R, Lu Y, et al
    Recombinant Zoster Vaccine (Shingrix) real-world effectiveness in the first two years post-licensure.
    Clin Infect Dis. 2021 Feb 13. pii: 6134290. doi: 10.1093.
    >> Share

  103. HARPAZ R
    The Effectiveness of Recombinant Zoster Vaccine: Observations in the Wild.
    Clin Infect Dis. 2021 Feb 13. pii: 6134291. doi: 10.1093.
    >> Share


  104. Corrigendum to: Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies.
    Clin Infect Dis. 2021 Feb 12. pii: 6134004. doi: 10.1093/cid/ciaa1767.
    >> Share

  105. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    >> Share

  106. WOLTER N, Cohen C, Tempia S, Walaza S, et al
    Epidemiology of pertussis in individuals of all ages hospitalised with respiratory illness in South Africa, January 2013 - December 2018.
    Clin Infect Dis. 2021 Feb 2. pii: 6126768. doi: 10.1093.
    >> Share

  107. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    >> Share

  108. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    >> Share

  109. ANDERSEN MA, Niemann CU, Rostgaard K, Dalby T, et al
    Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.
    Clin Infect Dis. 2021;72:463-471.
    >> Share

    January 2021
  110. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    >> Share

  111. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    >> Share

  112. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    >> Share

  113. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    >> Share

  114. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost Efectiveness of Universal Varicella Vaccination with Different Varicella Vaccines in the UK.
    Clin Infect Dis. 2021 Jan 28. pii: 6122568. doi: 10.1093.
    >> Share

  115. DAGAN R, van der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Effectiveness of the seven- and thirteen valent pneumococcal conjugate vaccines against vaccine-serotype otitis media.
    Clin Infect Dis. 2021 Jan 28. pii: 6122570. doi: 10.1093.
    >> Share

  116. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    >> Share

  117. CAMPBELL AP, Ogokeh C, Weinberg GA, Boom JA, et al
    Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated with B/Victoria Viruses, 2019-2020.
    Clin Infect Dis. 2021 Jan 27. pii: 6121316. doi: 10.1093.
    >> Share

  118. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    >> Share

  119. LONGLEY AT, Date K, Luby SP, Bhatnagar P, et al
    Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Clin Infect Dis. 2021 Jan 27. pii: 6121264. doi: 10.1093.
    >> Share

  120. MEISSNER HC, Plotkin SA
    The Facts About Vaccine Safety.
    Clin Infect Dis. 2021;72:309-310.
    >> Share

  121. MARTINS D, McCormack D, Tadrous M, Gomes T, et al
    Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study.
    Clin Infect Dis. 2021;72:279-284.
    >> Share

  122. VERHAGEN LM, Rivera-Olivero IA, Clerc M, Chu MLJN, et al
    Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections.
    Clin Infect Dis. 2021;72:212-221.
    >> Share

  123. VEKEMANS J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, et al
    Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework.
    Clin Infect Dis. 2021 Jan 25. pii: 6119610. doi: 10.1093.
    >> Share

  124. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    >> Share

  125. FERDINANDS JM, Gaglani M, Martin ET, Monto AS, et al
    Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    Clin Infect Dis. 2021 Jan 19. pii: 6104243. doi: 10.1093.
    >> Share

  126. LIPWORTH S, Vihta KD, Chau KK, Kavanagh J, et al
    Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections.
    Clin Infect Dis. 2021 Jan 7. pii: 6067638. doi: 10.1093.
    >> Share

  127. GRAVENSTEIN S, McConeghy KW, Saade E, Davidson HE, et al
    Adjuvanted influenza vaccine and influenza outbreaks in U.S. nursing homes: Results from a pragmatic cluster-randomized clinical trial.
    Clin Infect Dis. 2021 Jan 5. pii: 6064531. doi: 10.1093/cid/ciaa1916.
    >> Share

  128. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United
    Clin Infect Dis. 2021 Jan 5. pii: 6064642. doi: 10.1093/cid/ciaa1944.
    >> Share

  129. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    >> Share

  130. HUGHES K, Middleton DB, Nowalk MP, Balasubramani GK, et al
    Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
    Clin Infect Dis. 2021 Jan 3. pii: 6060064. doi: 10.1093/cid/ciaa1927.
    >> Share

    December 2020
  131. BOEY L, Curinckx A, Roelants M, Derdelinckx I, et al
    Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults.
    Clin Infect Dis. 2020 Dec 29. pii: 6054974. doi: 10.1093/cid/ciaa1897.
    >> Share

  132. TENFORDE MW, Kondor RJG, Chung JR, Zimmerman RK, et al
    Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.
    Clin Infect Dis. 2020 Dec 25. pii: 6048924. doi: 10.1093/cid/ciaa1884.
    >> Share

  133. CHUNG H, Buchan SA, Campigotto A, Campitelli MA, et al
    Influenza vaccine effectiveness against all-cause mortality following laboratory-confirmed influenza in older adults, 2010-2011 to 2015-2016 seasons in Ontario, Canada.
    Clin Infect Dis. 2020 Dec 23. pii: 6044622. doi: 10.1093/cid/ciaa1862.
    >> Share

  134. LEWNARD JA, Givon-Lavi N, Dagan R
    Effectiveness of pneumococcal conjugate vaccines against community-acquired alveolar pneumonia attributable to vaccine-serotype Streptococcus pneumoniae among children.
    Clin Infect Dis. 2020 Dec 21. pii: 6042567. doi: 10.1093/cid/ciaa1860.
    >> Share

  135. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    >> Share

  136. LADHANI SN, Borrow R, Ramsay ME
    Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program.
    Clin Infect Dis. 2020 Dec 19. pii: 6042098. doi: 10.1093/cid/ciaa1644.
    >> Share

  137. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    >> Share

  138. KLUGMAN KP, Rodgers GL
    Impact of pneumococcal conjugate vaccine on vaccine serotype specific pneumonia.
    Clin Infect Dis. 2020 Dec 18. pii: 6041689. doi: 10.1093/cid/ciaa1867.
    >> Share

  139. CARTER AS, Luby SP, Garrett DO
    Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.
    Clin Infect Dis. 2020;71.
    >> Share

    November 2020
  140. KOELMAN DLH, van Kassel MN, Bijlsma MW, Brouwer MC, et al
    Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: Three Decades of National Meningitis Surveillance in The Netherlands.
    Clin Infect Dis. 2020 Nov 28. pii: 6008501. doi: 10.1093/cid/ciaa1774.
    >> Share

  141. HOES J, Woestenberg PJ, Bogaards JA, King AJ, et al
    Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects.
    Clin Infect Dis. 2020 Nov 28. pii: 6010041. doi: 10.1093/cid/ciaa1770.
    >> Share

  142. MCMILLAN M, Chandrakumar A, Wang HLR, Clarke M, et al
    Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.
    Clin Infect Dis. 2020 Nov 19. pii: 5992465. doi: 10.1093/cid/ciaa1733.
    >> Share

  143. IZURIETA HS, Lu M, Kelman J, Lu Y, et al
    Comparative effectiveness of influenza vaccines among U.S. Medicare beneficiaries ages 65 years and older during the 2019-20 season.
    Clin Infect Dis. 2020 Nov 19. pii: 5992287. doi: 10.1093/cid/ciaa1727.
    >> Share

  144. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    >> Share

  145. TEH BW, Leung VKY, Mordant FL, Sullivan SG, et al
    A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation.
    Clin Infect Dis. 2020 Nov 11. pii: 5974227. doi: 10.1093/cid/ciaa1711.
    >> Share

  146. AKPO EIH, Cristeau O, Hunjan M, Casabona G, et al
    Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom (UK).
    Clin Infect Dis. 2020 Nov 11. pii: 5973941. doi: 10.1093/cid/ciaa1708.
    >> Share

  147. NIANG MN, Sugimoto JD, Diallo A, Diarra B, et al
    Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011.
    Clin Infect Dis. 2020 Nov 9. pii: 5963906. doi: 10.1093/cid/ciaa1689.
    >> Share

  148. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    >> Share

  149. PELTON SI, Lapidot R
    Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network.
    Clin Infect Dis. 2020 Nov 5. pii: 5957066. doi: 10.1093/cid/ciaa1688.
    >> Share

  150. SHINDE V, Cai R, Plested J, Cho I, et al
    Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
    Clin Infect Dis. 2020 Nov 4. pii: 5955953. doi: 10.1093/cid/ciaa1673.
    >> Share

    October 2020
  151. ESAULENKO EV, Yakovlev AA, Volkov GA, Sukhoruk AA, et al
    Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 randomized clinical trial in the Russian Federation.
    Clin Infect Dis. 2020 Oct 29. pii: 5942941. doi: 10.1093/cid/ciaa1649.
    >> Share

  152. UJIIE M
    Trends in the incidence of reported adverse events after changing the Bacillus Calmette-Guerin vaccination age in Japan.
    Clin Infect Dis. 2020 Oct 28. pii: 5942531. doi: 10.1093/cid/ciaa1640.
    >> Share

  153. BAANDRUP L, Dehlendorff C, Kjaer SK
    One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
    Clin Infect Dis. 2020 Oct 13. pii: 5922377. doi: 10.1093/cid/ciaa1067.
    >> Share

  154. PAVLINAC PB, Platts-Mills JA, Tickell KD, Liu J, et al
    The clinical presentation of culture-positive and culture-negative, qPCR-attributable shigellosis in the Global Enteric Multicenter Study and derivation of a Shigella severity score: implications for pediatric Shigella vaccine trials.
    Clin Infect Dis. 2020 Oct 12. pii: 5921054. doi: 10.1093/cid/ciaa1545.
    >> Share

    September 2020
  155. XIE H, Xiang R, Wan HJ, Plant EP, et al
    Reduced Influenza B-specific Post-Vaccination Antibody Cross-reactivity in the B/Victoria Lineage Predominant 2019/20 Season.
    Clin Infect Dis. 2020 Sep 29. pii: 5912827. doi: 10.1093/cid/ciaa1481.
    >> Share

  156. BARDENHEIER BH, Baier RR, Silva JB, Gravenstein S, et al
    Persistence of Racial Inequities in Receipt of Influenza Vaccination among Nursing Home Residents in the United States.
    Clin Infect Dis. 2020 Sep 29. pii: 5912795. doi: 10.1093/cid/ciaa1484.
    >> Share

  157. DE MIGUEL S, Domenech M, Gonzalez-Camacho F, Sempere J, et al
    Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era.
    Clin Infect Dis. 2020 Sep 29. pii: 5912816. doi: 10.1093/cid/ciaa1483.
    >> Share

  158. FIRNHABER C, Swarts A, Jezile V, Mulongo M, et al
    HPV Vaccination Prior to Loop Electroexcision Procedure does not Prevent Recurrent Cervical High Grade Squamous Intraepithelial Lesions in Women Living with HIV: a Randomized, Double-blind, Placebo-controlled Trial.
    Clin Infect Dis. 2020 Sep 25. pii: 5911567. doi: 10.1093/cid/ciaa1456.
    >> Share

  159. FELDSTEIN LR, Self WH, Ferdinands JM, Randolph AG, et al
    Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND).
    Clin Infect Dis. 2020 Sep 25. pii: 5911459. doi: 10.1093/cid/ciaa1453.
    >> Share

  160. PLUMB ID, Gounder PP, Nolen LD, Massay SC, et al
    Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018.
    Clin Infect Dis. 2020 Sep 24. pii: 5910738. doi: 10.1093/cid/ciaa1102.
    >> Share

  161. ANDERSEN A, Fisker AB, Nielsen S, Rodrigues A, et al
    National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area.
    Clin Infect Dis. 2020 Sep 19. pii: 5909021. doi: 10.1093/cid/ciaa1351.
    >> Share

  162. ANDERSON EJ, Campbell JD, Creech CB, Frenck R, et al
    Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
    Clin Infect Dis. 2020 Sep 18. pii: 5908283. doi: 10.1093/cid/ciaa1425.
    >> Share

  163. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    >> Share

  164. WANG W, Alvarado-Facundo E, Vassell R, Collins L, et al
    Comparison of A(H3N2) neutralizing antibody responses elicited by 2018-2019 season quadrivalent influenza vaccines derived from eggs, cells, and recombinant hemagglutinin.
    Clin Infect Dis. 2020 Sep 8. pii: 5902974. doi: 10.1093/cid/ciaa1352.
    >> Share

  165. MCCONEGHY KW, Davidson HE, Canaday DH, Han L, et al
    Cluster-randomized trial of adjuvanted vs. non-adjuvanted trivalent influenza vaccine in 823 U.S. nursing homes.
    Clin Infect Dis. 2020 Sep 4. pii: 5901187. doi: 10.1093/cid/ciaa1233.
    >> Share

    August 2020
  166. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First real world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease; prospective enhanced national surveillance, England.
    Clin Infect Dis. 2020 Aug 26. pii: 5897488. doi: 10.1093/cid/ciaa1244.
    >> Share

  167. MARSHALL HS, Maiden MCJ
    The impact of a meningococcal protein-based serogroup B vaccine on serogroup W invasive disease in children.
    Clin Infect Dis. 2020 Aug 26. pii: 5897487. doi: 10.1093/cid/ciaa1253.
    >> Share

  168. DE CHAISEMARTIN C, de Chaisemartin L
    BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden.
    Clin Infect Dis. 2020 Aug 23. pii: 5896039. doi: 10.1093/cid/ciaa1223.
    >> Share

  169. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation age of Bacillus Calmette-Guerin Tokyo-172 strain and vaccine-related adverse reactions in Taiwan birth cohort of 2012-2017.
    Clin Infect Dis. 2020 Aug 22. pii: 5895968. doi: 10.1093/cid/ciaa1235.
    >> Share

  170. KIRWAN PD, Amin-Chowdhury Z, Croxford SE, Sheppard C, et al
    Invasive Pneumococcal Disease in People With Human Immunodeficiency Virus in England, 1999-2017.
    Clin Infect Dis. 2020 Aug 13. pii: 5892189. doi: 10.1093.
    >> Share

  171. GONZALEZ-RUBIO F, Ioakeim-Skoufa I, Poblador-Plou B, Gimeno-Miguel A, et al
    Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics.
    Clin Infect Dis. 2020 Aug 11. pii: 5891288. doi: 10.1093/cid/ciaa1190.
    >> Share

  172. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events among Young Adults following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2020 Aug 7. pii: 5885122. doi: 10.1093/cid/ciaa1090.
    >> Share

  173. GIBNEY KB, MacLachlan J, Coutts R, Higgins N, et al
    Incidence of invasive pneumococcal disease higher among people notified with markers of hepatitis C virus infection: Population-based surveillance in Victoria, Australia 2001-2017.
    Clin Infect Dis. 2020 Aug 4. pii: 5880584. doi: 10.1093/cid/ciaa1110.
    >> Share

    July 2020
  174. MUHIB FB, Pecenka CJ, Marfin AA
    Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction.
    Clin Infect Dis. 2020;71.
    >> Share

  175. SOBLE A, Patel Z, Sosler S, Hampton L, et al
    Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction.
    Clin Infect Dis. 2020;71.
    >> Share

  176. DATE K, Shimpi R, Luby S, N R, et al
    Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Clin Infect Dis. 2020;71.
    >> Share

  177. BALIBAN SM, Lu YJ, Malley R
    Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects.
    Clin Infect Dis. 2020;71.
    >> Share

  178. NEUZIL KM, Basnyat B, Clemens JD, Gordon MA, et al
    Early Insights From Clinical Trials of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2020;71.
    >> Share

  179. SYED KA, Saluja T, Cho H, Hsiao A, et al
    Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead.
    Clin Infect Dis. 2020;71.
    >> Share

  180. STEELE AD, Carey ME, Kumar S, MacLennan CA, et al
    Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
    Clin Infect Dis. 2020;71.
    >> Share

  181. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2020 Jul 27. pii: 5876773. doi: 10.1093/cid/ciaa1045.
    >> Share

  182. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    BCG infections at high frequency in both AR-CGD and X-CGD patients following BCG vaccination.
    Clin Infect Dis. 2020 Jul 27. pii: 5876589. doi: 10.1093/cid/ciaa1049.
    >> Share

  183. ROSITCH AF, Patel EU, Petersen MR, Quinn TC, et al
    Importance of lifetime sexual history on the prevalence of genital human papillomavirus among unvaccinated adults in NHANES: implications for adult HPV vaccination.
    Clin Infect Dis. 2020 Jul 25. pii: 5876408. doi: 10.1093/cid/ciaa1050.
    >> Share

  184. PLOTKIN SA
    The Value of Human Challenges in SARS-2-nCoV Vaccine Development.
    Clin Infect Dis. 2020 Jul 16. pii: 5872587. doi: 10.1093/cid/ciaa1013.
    >> Share

  185. DE GRAAF H, Ibrahim M, Hill AR, Gbesemete D, et al
    Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.
    Clin Infect Dis. 2020;71:403-411.
    >> Share

  186. CONGDON M, Hong H, Young RR, Cunningham CK, et al
    Effect of Haemophilus influenzae type b and 13-valent pneumococcal conjugate vaccines on childhood pneumonia hospitalizations and deaths in Botswana.
    Clin Infect Dis. 2020 Jul 8. pii: 5868543. doi: 10.1093.
    >> Share

  187. NGUYEN LC, Bakerlee CW, McKelvey TG, Rose SM, et al
    Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development.
    Clin Infect Dis. 2020 Jul 6. pii: 5868014. doi: 10.1093.
    >> Share

    June 2020
  188. ULANOVA M
    Invasive Haemophilus influenzae serotype a disease in the Hib conjugate vaccine era: where are we going?
    Clin Infect Dis. 2020 Jun 26. pii: 5863388. doi: 10.1093.
    >> Share

  189. USUF E, Christian B, Gladstone R, Bojang E, et al
    Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after ten years of pneumococcal conjugate vaccine pressure.
    Clin Infect Dis. 2020 Jun 25. pii: 5862674. doi: 10.1093.
    >> Share

  190. BEN-SHIMOL S, Dagan R, Givon-Lavi N, Avital D, et al
    Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
    Clin Infect Dis. 2020;71:177-187.
    >> Share

  191. PEPPA M, Thomas SL, Minassian C, Walker JL, et al
    Seasonal influenza vaccination during pregnancy and the risk of major congenital malformations in live-born infants: A 2010-2016 historical cohort study.
    Clin Infect Dis. 2020 Jun 23. pii: 5861001. doi: 10.1093.
    >> Share

  192. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
    Impact of extending the timing of maternal pertussis vaccination on hospitalized infant pertussis in England, 2014 - 2018.
    Clin Infect Dis. 2020 Jun 22. pii: 5860914. doi: 10.1093.
    >> Share

  193. HUNG IF, Yap DY, Yip TP, Zhang RR, et al
    A double-blind randomized phase 2 controlled trial of intradermal hepatitis B vaccination with a topical Toll-like receptor 7 agonist imiquimod, in patients on dialysis.
    Clin Infect Dis. 2020 Jun 18. pii: 5859563. doi: 10.1093.
    >> Share

  194. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential HBV Vaccination Increases HBsAg Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2020 Jun 18. pii: 5859569. doi: 10.1093.
    >> Share

  195. KITT E, Burt S, Price SM, Satchell L, et al
    Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience.
    Clin Infect Dis. 2020 Jun 17. pii: 5858929. doi: 10.1093.
    >> Share

  196. BARRETT ADT
    Is it time to re-evaluate the priority for a WN vaccine.
    Clin Infect Dis. 2020 Jun 11. pii: 5856140. doi: 10.1093.
    >> Share

  197. HEININGER U
    Diphtheria, tetanus and pertussis: unequal vaccine siblings with distinct characteristics.
    Clin Infect Dis. 2020 Jun 9. pii: 5855254. doi: 10.1093.
    >> Share

  198. KIM SS, Flannery B, Foppa IM, Chung JR, et al
    Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18.
    Clin Infect Dis. 2020 Jun 7. pii: 5854319. doi: 10.1093.
    >> Share

  199. MEISSNER HC, Plotkin SA
    The Facts About Vaccine Safety.
    Clin Infect Dis. 2020 Jun 6. pii: 5854159. doi: 10.1093.
    >> Share

  200. CANADAY DH, Gravenstein S
    On setting expectations for a SARS-CoV-2 Vaccine.
    Clin Infect Dis. 2020 Jun 4. pii: 5851447. doi: 10.1093.
    >> Share

  201. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing SARS-CoV-2 Vaccines in Children.
    Clin Infect Dis. 2020 Jun 3. pii: 5850904. doi: 10.1093.
    >> Share

    May 2020
  202. HELLARD M, Drummer H, Scott N
    Striving for hepatitis C elimination - the role of a vaccine.
    Clin Infect Dis. 2020 May 25. pii: 5843664. doi: 10.1093.
    >> Share

  203. DE OLIVEIRA LH, Shioda K, Valenzuela MT, Janusz CB, et al
    Declines in pneumonia mortality following the introduction of pneumococcal conjugate vaccines in Latin American and Caribbean countries.
    Clin Infect Dis. 2020 May 25. pii: 5843625. doi: 10.1093.
    >> Share

  204. MCMILLAN M, Walters L, Sullivan T, Leong LEX, et al
    Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents.
    Clin Infect Dis. 2020 May 24. pii: 5843568. doi: 10.1093.
    >> Share

  205. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2020 May 23. pii: 5911475. doi: 10.1093.
    >> Share

  206. MAIER HE, Nachbagauer R, Kuan G, Ng S, et al
    Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
    Clin Infect Dis. 2020;70:2290-2297.
    >> Share

  207. COX A, Sulkowski M, Sugarman J
    Ethical and Practical Issues Associated with the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine.
    Clin Infect Dis. 2020 May 22. pii: 5842210. doi: 10.1093.
    >> Share

  208. SKOWRONSKI DM, Zou M, Clarke Q, Chambers C, et al
    Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17.
    Clin Infect Dis. 2020 May 22. pii: 5842161. doi: 10.1093.
    >> Share

  209. WOESTENBERG PJ, Guevara Morel AE, Bogaards JA, Hooiveld M, et al
    Partial protective effect of bivalent HPV16/18 vaccination against anogenital warts in a large cohort of Dutch primary care patients.
    Clin Infect Dis. 2020 May 17. pii: 5839810. doi: 10.1093.
    >> Share

  210. MARTINEZ-BAZ I, Navascues A, Portillo ME, Casado I, et al
    Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus.
    Clin Infect Dis. 2020 May 15. pii: 5837528. doi: 10.1093.
    >> Share

  211. CROWCROFT NS, Schwartz KL, Savage RD, Chen C, et al
    A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: A Canadian Immunization Research Network Study.
    Clin Infect Dis. 2020 May 8. pii: 5834736. doi: 10.1093.
    >> Share

  212. LEWNARD JA, King LM, Fleming-Dutra KE, Link-Gelles R, et al
    Incidence of pharyngitis, sinusitis, acute otitis media, and outpatient antibiotic prescribing preventable by vaccination against group A Streptococcus in the United States.
    Clin Infect Dis. 2020 May 6. pii: 5831353. doi: 10.1093.
    >> Share

  213. TANZ RR, Shulman ST
    Antimicrobial Stewardship: A Potentially Important Benefit of a Group A Streptococcus Vaccine in Areas with Low Rates of Acute Rheumatic Fever.
    Clin Infect Dis. 2020 May 6. pii: 5831337. doi: 10.1093.
    >> Share

  214. MATRAJT L, Halloran ME, Antia R
    Reply to Lindsey, Hoschler, and de Silva.
    Clin Infect Dis. 2020;70:2236-2237.
    >> Share

    April 2020
  215. BURKE RM, Groom HC, Naleway AL, Katz EM, et al
    Rotavirus Vaccine is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results from the MAAGE Study.
    Clin Infect Dis. 2020 Apr 23. pii: 5823955. doi: 10.1093.
    >> Share

  216. SMITH ER, Fry AM, Hicks LA, Fleming-Dutra KE, et al
    Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination.
    Clin Infect Dis. 2020 Apr 23. pii: 5823940. doi: 10.1093.
    >> Share

  217. MCATEER J, Yildirim I, Chahroudi A
    The VACCINES Act, Deciphering Vaccine Hesitancy in the Time of COVID19.
    Clin Infect Dis. 2020 Apr 13. pii: 5819529. doi: 10.1093.
    >> Share

  218. TENFORDE MW, Chung J, Smith ER, Talbot HK, et al
    Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018.
    Clin Infect Dis. 2020 Apr 9. pii: 5818114. doi: 10.1093.
    >> Share

  219. BOIKOS C, Sylvester GC, Sampalis JS, Mansi JA, et al
    Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-Derived Quadrivalent Influenza Vaccines in Preventing Influenza-Like Illness in 2017-2018.
    Clin Infect Dis. 2020 Apr 7. pii: 5816768. doi: 10.1093.
    >> Share

  220. NAYAGAM S, Chan P, Zhao K, Sicuri E, et al
    Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Clin Infect Dis. 2020 Apr 7. pii: 5817057. doi: 10.1093.
    >> Share

    March 2020
  221. TOKARS JI, Patel MM, Foppa IM, Reed C, et al
    Waning of measured influenza vaccine effectiveness over time: the potential contribution of leaky vaccine effect.
    Clin Infect Dis. 2020 Mar 28. pii: 5813486. doi: 10.1093.
    >> Share

  222. DIAZGRANADOS CA, Langevin E, Bonaparte M, Sridhar S, et al
    CYD-TDV dengue vaccine performance by baseline immune profile (monotypic/multitypic) in dengue seropositive individuals.
    Clin Infect Dis. 2020 Mar 21. pii: 5810750. doi: 10.1093.
    >> Share

  223. YIN S, Barker L, Ly KN, Kilmer G, et al
    Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.
    Clin Infect Dis. 2020 Mar 20. pii: 5810334. doi: 10.1093.
    >> Share

  224. SHANN F
    A live-vaccine-last schedule: saving an extra million lives a year?
    Clin Infect Dis. 2020 Mar 18. pii: 5809306. doi: 10.1093.
    >> Share

  225. CLIPET-JENSEN C, Andersen A, Jensen AKG, Aaby P, et al
    Out-of-sequence vaccinations with measles vaccine and diphtheria-tetanus-pertussis vaccine. A re-analysis of demographic surveillance data from rural Bangladesh.
    Clin Infect Dis. 2020 Mar 18. pii: 5809305. doi: 10.1093.
    >> Share

  226. HOWARD L, de St Maurice A
    Unraveling the Impact of Pneumococcal Conjugate Vaccines on Bacterial Conjunctivitis in Children.
    Clin Infect Dis. 2020 Mar 4. pii: 5783061. doi: 10.1093.
    >> Share

  227. GIBNEY KB, Attwood LO, Nicholson S, Tran T, et al
    Emergence of Attenuated Measles Illness Among IgG-positive/IgM-negative Measles Cases: Victoria, Australia, 2008-2017.
    Clin Infect Dis. 2020;70:1060-1067.
    >> Share

    February 2020
  228. SLIFKA AM, Park B, Gao L, Slifka MK, et al
    Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules.
    Clin Infect Dis. 2020 Feb 25. pii: 5741633. doi: 10.1093.
    >> Share

  229. MCINTYRE P
    Challenges in valuing vaccine prevention of severe early infant infections.
    Clin Infect Dis. 2020 Feb 25. pii: 5754206. doi: 10.1093.
    >> Share

  230. SANDMANN F, Jit M, Andrews N, Buckley HL, et al
    Infant hospitalisations and fatalities averted by the maternal pertussis vaccination programme in England, 2012-2017: Post-implementation economic evaluation.
    Clin Infect Dis. 2020 Feb 25. pii: 5754490. doi: 10.1093.
    >> Share

  231. DOYLE JD, Beacham L, Martin ET, Talbot HK, et al
    Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017.
    Clin Infect Dis. 2020 Feb 18. pii: 5739665. doi: 10.1093.
    >> Share

  232. TOP KA, Vaudry W, Morris SK, Pham-Huy A, et al
    Waning vaccine immunity and vaccination responses in children treated for acute lymphoblastic leukemia: A Canadian Immunization Research Network Study.
    Clin Infect Dis. 2020 Feb 18. pii: 5739670. doi: 10.1093.
    >> Share

  233. KAUR R, Pham M, Yu KOA, Pichichero ME, et al
    Rising Pneumococcal Antibiotic Resistance in the Post 13-valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates from a Primary Care Setting.
    Clin Infect Dis. 2020 Feb 18. pii: 5739663. doi: 10.1093.
    >> Share

  234. MARTIN KG, Banerjee E, McMahon M, Kenyon C, et al
    Identifying Vaccine-Associated Rash Illness Amidst a Large Measles Outbreak - Minnesota, 2017.
    Clin Infect Dis. 2020 Feb 18. pii: 5739707. doi: 10.1093.
    >> Share

  235. STAAT MA, Payne DC, Halasa N, Weinberg GA, et al
    Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016.
    Clin Infect Dis. 2020 Feb 15. pii: 5736374. doi: 10.1093.
    >> Share

  236. MCGEE L, Chochua S, Li Z, Mathis S, et al
    Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017.
    Clin Infect Dis. 2020 Feb 15. pii: 5736375. doi: 10.1093.
    >> Share

  237. MONTO AS, Fukuda K
    Lessons From Influenza Pandemics of the Last 100 Years.
    Clin Infect Dis. 2020;70:951-957.
    >> Share

  238. HALASA N, Piya B, Stewart LS, Rahman H, et al
    The Changing Landscape of Pediatric Viral Enteropathogens in the Post-Rotavirus Vaccine Era.
    Clin Infect Dis. 2020 Feb 3. pii: 5721141. doi: 10.1093.
    >> Share

  239. VINK P
    Reply to Cheng et al and Nellore et al.
    Clin Infect Dis. 2020;70:720-721.
    >> Share

  240. NELLORE A, Mannon RB, Limaye AP
    Letter to the Editor.
    Clin Infect Dis. 2020;70:719.
    >> Share

  241. GAGLANI M, Vasudevan A, Raiyani C, Murthy K, et al
    Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017.
    Clin Infect Dis. 2020 Feb 1. pii: 5719597. doi: 10.1093.
    >> Share

    January 2020
  242. DAGAN R, Jiang Q, Juergens C, Trammel J, et al
    Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: The Influence of Serotypes, Timing, and Previous Vaccine Dose Unraveled.
    Clin Infect Dis. 2020 Jan 29. pii: 5717351. doi: 10.1093.
    >> Share

  243. BAUM U, Kulathinal S, Auranen K, Nohynek H, et al
    Effectiveness of two influenza vaccines in nationwide cohorts of Finnish two-year-old children in the seasons 2015/16-2017/18.
    Clin Infect Dis. 2020 Jan 19. pii: 5709633. doi: 10.1093.
    >> Share

  244. AMIN-CHOWDHURY Z, Collins S, Sheppard C, Litt D, et al
    Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18.
    Clin Infect Dis. 2020 Jan 19. pii: 5709629. doi: 10.1093.
    >> Share

  245. CHUNG JR, Rolfes MA, Flannery B, Prasad P, et al
    Effects of Influenza Vaccination in the United States during the 2018-2019 Influenza Season.
    Clin Infect Dis. 2020 Jan 6. pii: 5697292. doi: 10.1093/cid/ciz1244.
    >> Share

  246. WHITTLES LK, White PJ, Didelot X
    Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics.
    Clin Infect Dis. 2020 Jan 6. pii: 5697289. doi: 10.1093/cid/ciz1241.
    >> Share

  247. NATION ML, Moss R, Spittal MJ, Kotsimbos T, et al
    Influenza vaccine effectiveness against influenza-related mortality in Australian hospitalized patients: a propensity score analysis.
    Clin Infect Dis. 2020 Jan 6. pii: 5696795. doi: 10.1093/cid/ciz1238.
    >> Share

  248. HOSSEINIPOUR MC, Innes C, Naidoo S, Mann P, et al
    Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein.
    Clin Infect Dis. 2020 Jan 4. pii: 5695901. doi: 10.1093/cid/ciz1239.
    >> Share

    December 2019
  249. HEAD JR, Collender PA, Lewnard JA, Skaff NK, et al
    Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011-2018: a longitudinal surveillance study.
    Clin Infect Dis. 2019 Dec 27. pii: 5687873. doi: 10.1093/cid/ciz1188.
    >> Share

  250. LIU F, Levine MZ
    Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination against Newly Emerged 2016-2018 A(H3N2) Variant Viruses in Healthy Persons.
    Clin Infect Dis. 2019 Dec 20. pii: 5681550. doi: 10.1093/cid/ciz1203.
    >> Share

  251. WHILEY DM, Ye S, Tozer S, Clark JE, et al
    Over-diagnosis of rotavirus infection in infants due to detection of vaccine virus.
    Clin Infect Dis. 2019 Dec 18. pii: 5680199. doi: 10.1093/cid/ciz1196.
    >> Share

  252. COWLING BJ, Perera RAPM, Valkenburg SA, Leung NHL, et al
    Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
    Clin Infect Dis. 2019 Dec 12. pii: 5673516. doi: 10.1093/cid/ciz1034.
    >> Share

  253. ROBIN C, Bahuaud M, Redjoul R, Jeljeli M, et al
    ANTIPNEUMOCOCCAL SEROPROTECTION YEARS AFTER VACCINATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS.
    Clin Infect Dis. 2019 Dec 4. pii: 5651221. doi: 10.1093/cid/ciz1168.
    >> Share

    November 2019
  254. LEWNARD JA, Givon-Lavi N, Dagan R
    Dose-specific effectiveness of 7- and 13-valent pneumococcal conjugate vaccines against vaccine-serotype Streptococcus pneumoniae colonization in children.
    Clin Infect Dis. 2019 Nov 30. pii: 5648116. doi: 10.1093/cid/ciz1164.
    >> Share

  255. JONGO SA, Church LWP, Mtoro AT, Chakravarty S, et al
    Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults.
    Clin Infect Dis. 2019 Nov 29. pii: 5647428. doi: 10.1093/cid/ciz1152.
    >> Share

  256. GUAN X, Che Y, Wei S, Li S, et al
    Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study.
    Clin Infect Dis. 2019 Nov 18. pii: 5627780. doi: 10.1093/cid/ciz1114.
    >> Share

  257. VASILEIOU E, Sheikh A, Butler CC, Robertson C, et al
    Seasonal influenza vaccine effectiveness in people with asthma: a national test-negative design case-control study.
    Clin Infect Dis. 2019 Nov 5. pii: 5613421. doi: 10.1093/cid/ciz1086.
    >> Share


  258. Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine.
    Clin Infect Dis. 2019 Nov 4. pii: 5611152. doi: 10.1093/cid/ciz1056.
    >> Share

  259. KEAM B, Kang CK, Jun KI, Moon SM, et al
    Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor.
    Clin Infect Dis. 2019 Nov 4. pii: 5611338. doi: 10.1093/cid/ciz1092.
    >> Share

  260. SCHALTZ-BUCHHOLZER F, Bjerregaard-Andersen M, Oland CB, Golding C, et al
    Early vaccination with BCG-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: A randomized controlled trial.
    Clin Infect Dis. 2019 Nov 3. pii: 5611188. doi: 10.1093/cid/ciz1080.
    >> Share

  261. MCKAY SL, Guo A, Pergam SA, Dooling K, et al
    Herpes zoster risk in immunocompromised adults in the United States: A systematic review.
    Clin Infect Dis. 2019 Nov 2. pii: 5611148. doi: 10.1093/cid/ciz1090.
    >> Share

    October 2019
  262. CAREY ME, Steele AD
    The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines.
    Clin Infect Dis. 2019;69.
    >> Share

  263. JEON HJ, Im J, Haselbeck A, Holm M, et al
    How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
    Clin Infect Dis. 2019;69.
    >> Share

  264. GARCIA GARRIDO HM, Mak AMR, Wit FWNM, Wong GWM, et al
    Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
    Clin Infect Dis. 2019 Oct 21. pii: 5601907. doi: 10.1093.
    >> Share

  265. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    >> Share

  266. GOMES-SOLECKI M, Arnaboldi PM, Backenson PB, Benach JL, et al
    Protective Immunity and New Vaccines for Lyme Disease.
    Clin Infect Dis. 2019 Oct 17. pii: 5588349. doi: 10.1093.
    >> Share

  267. LEVIN MJ, Weinberg A
    Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine.
    Clin Infect Dis. 2019 Oct 16. pii: 5588657. doi: 10.1093.
    >> Share

  268. MEIRING JE, Giubilini A, Savulescu J, Pitzer VE, et al
    Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge.
    Clin Infect Dis. 2019;69.
    >> Share

  269. CAREY ME, Diaz ZI, Broadstock M, Bailey R, et al
    Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    >> Share

  270. GOUMA S, Zost SJ, Parkhouse K, Branche A, et al
    Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season.
    Clin Infect Dis. 2019 Oct 9. pii: 5584829. doi: 10.1093.
    >> Share

  271. BATE J, Borrow R, Chisholm J, Clark S, et al
    13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment.
    Clin Infect Dis. 2019 Oct 5. pii: 5581576. doi: 10.1093.
    >> Share

    September 2019
  272. DHAR N, Kwatra G, Nunes MC, Cutland C, et al
    Hemagglutinin-stalk antibody responses following trivalent inactivated influenza vaccine immunization of pregnant women and association with protection from influenza virus illness.
    Clin Infect Dis. 2019 Sep 27. pii: 5575323. doi: 10.1093.
    >> Share

  273. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    >> Share

  274. OTIENO GP, Bottomley C, Khagayi S, Adetifa I, et al
    Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhoea among children in Kenya: A controlled interrupted time series analysis.
    Clin Infect Dis. 2019 Sep 23. pii: 5572563. doi: 10.1093.
    >> Share

  275. STEELE AD, Groome MJ
    Measuring Rotavirus Vaccine Impact in sub-Saharan Africa.
    Clin Infect Dis. 2019 Sep 23. pii: 5572561. doi: 10.1093.
    >> Share

  276. THEILACKER C, Vyse A, Jodar L, Gessner BD, et al
    Evaluations of the Public Health Impact of Adult Vaccination with Pneumococcal Vaccines Should Include Reductions in All-Cause Pneumonia.
    Clin Infect Dis. 2019 Sep 7. pii: 5564855. doi: 10.1093.
    >> Share

  277. DONKEN R, Dobson SRM, Marty KD, Cook D, et al
    Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
    Clin Infect Dis. 2019 Sep 6. pii: 5564371. doi: 10.1093.
    >> Share

  278. KOURNA HAMA M, Khan D, Laouali B, Okoi C, et al
    Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    >> Share

  279. SONKO MA, Dube FS, Okoi CB, Diop A, et al
    Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    >> Share

  280. SANNEH B, Okoi C, Grey-Johnson M, Bah-Camara H, et al
    Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019;69.
    >> Share

  281. BOULA A, Senghore M, Ngoh R, Tassadjo F, et al
    Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaounde, Cameroon, in the Post-Vaccine Era.
    Clin Infect Dis. 2019;69.
    >> Share

  282. ANDRIATAHIRINTSOA EJPR, Raboba JL, Rahajamanana VL, Rakotozanany AL, et al
    Impact of 10-Valent Pneumococcal Conjugate Vaccine on Bacterial Meningitis in Madagascar.
    Clin Infect Dis. 2019;69.
    >> Share

  283. DONDO V, Mujuru H, Nathoo K, Jacha V, et al
    Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
    Clin Infect Dis. 2019;69.
    >> Share

  284. AGOSSOU J, Ebruke C, Noudamadjo A, Adedemy JD, et al
    Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011-2016.
    Clin Infect Dis. 2019;69.
    >> Share

  285. MWENDA JM, Soda E, Weldegebriel G, Katsande R, et al
    Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016.
    Clin Infect Dis. 2019;69.
    >> Share

  286. MPABALWANI EM, Lukwesa-Musyani C, Imamba A, Nakazwe R, et al
    Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.
    Clin Infect Dis. 2019;69.
    >> Share

  287. TAGBO BN, Bancroft RE, Fajolu I, Abdulkadir MB, et al
    Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
    Clin Infect Dis. 2019;69.
    >> Share

  288. FAYE PM, Sonko MA, Diop A, Thiongane A, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Clin Infect Dis. 2019;69.
    >> Share

  289. BONI-CISSE C, Jarju S, Bancroft RE, Lepri NA, et al
    Etiology of Bacterial Meningitis Among Children <5 Years Old in Cote d'Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    >> Share

  290. RENNER LA, Usuf E, Mohammed NI, Ansong D, et al
    Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana.
    Clin Infect Dis. 2019;69.
    >> Share

  291. TSOLENYANU E, Bancroft RE, Sesay AK, Senghore M, et al
    Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lome, Togo.
    Clin Infect Dis. 2019;69.
    >> Share

    August 2019
  292. CASTELLI F
    Waiting for the malaria vaccine. The complex epidemiological transition towards malaria elimination.
    Clin Infect Dis. 2019 Aug 27. pii: 5555349. doi: 10.1093.
    >> Share

  293. LIU B, He WQ, Newall AT, Quinn HE, et al
    Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study.
    Clin Infect Dis. 2019 Aug 26. pii: 5554689. doi: 10.1093.
    >> Share

  294. AKECH S, Chepkirui M, Ogero M, Agweyu A, et al
    The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya.
    Clin Infect Dis. 2019 Aug 26. pii: 5554744. doi: 10.1093.
    >> Share

  295. CROWCROFT NS
    Pertussis vaccine is only modestly effective in adults: Another piece in the pertussis puzzle.
    Clin Infect Dis. 2019 Aug 26. pii: 5554663. doi: 10.1093.
    >> Share

  296. KUSHNER T, Chen Z, Tressler S, Kaufman H, et al
    Trends in Hepatitis B Infection and Immunity among Women of Childbearing Age in the United States.
    Clin Infect Dis. 2019 Aug 26. pii: 5554743. doi: 10.1093.
    >> Share

  297. CHENG MP, Quach C, Marty FM
    Herpes Zoster Subunit Vaccination for Renal Transplant Recipients.
    Clin Infect Dis. 2019 Aug 24. pii: 5554150. doi: 10.1093.
    >> Share

  298. WANLAPAKORN N, Maertens K, Vongpunsawad S, Peunpa J, et al
    Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial.
    Clin Infect Dis. 2019 Aug 16. pii: 5550660. doi: 10.1093.
    >> Share

  299. PEAK CM, Stous SS, Healy JM, Hofmeister MG, et al
    Homelessness and Hepatitis A - San Diego County, 2016-2018.
    Clin Infect Dis. 2019 Aug 15. pii: 5550168. doi: 10.1093.
    >> Share

  300. LINDSEY BB, Hoschler K, de Silva TI
    Complexities in predicting the immunogenicity of live attenuated influenza vaccines.
    Clin Infect Dis. 2019 Aug 14. pii: 5549953. doi: 10.1093.
    >> Share

  301. MONTO AS
    Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far?
    Clin Infect Dis. 2019 Aug 13. pii: 5549602. doi: 10.1093.
    >> Share

  302. JACKSON D, Pitcher M, Hudson C, Andrews N, et al
    Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016-2017 and 2017-2018 Influenza Seasons in the United Kingdom.
    Clin Infect Dis. 2019 Aug 13. pii: 5549573. doi: 10.1093.
    >> Share

  303. WEINBERGER DM, Shapiro ED
    Pneumococcal Vaccines for Adults: What's Next?
    Clin Infect Dis. 2019 Aug 12. pii: 5546063. doi: 10.1093.
    >> Share

  304. AHMED SS, Pondo T, Xing W, McGee L, et al
    Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States.
    Clin Infect Dis. 2019 Aug 12. pii: 5546062. doi: 10.1093.
    >> Share

  305. GOUMA S, Weirick M, Hensley SE
    Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.
    Clin Infect Dis. 2019 Aug 11. pii: 5546015. doi: 10.1093.
    >> Share

  306. LEROUX-ROELS G, Bebia Z, Maes C, Aerssens A, et al
    Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial.
    Clin Infect Dis. 2019 Aug 8. pii: 5545276. doi: 10.1093.
    >> Share

  307. MEDER KN, Jayasinghe S, Beard F, Dey A, et al
    Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalisations in Indigenous and non-Indigenous Australians.
    Clin Infect Dis. 2019 Aug 7. pii: 5544590. doi: 10.1093.
    >> Share

  308. WIESE AD, Grijalva CG
    To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program.
    Clin Infect Dis. 2019 Aug 7. pii: 5544622. doi: 10.1093.
    >> Share

    July 2019
  309. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Depletion of Susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2019 Jul 28. pii: 5540005. doi: 10.1093.
    >> Share

  310. HUGHES MM, Reed C, Flannery B, Garg S, et al
    Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States.
    Clin Infect Dis. 2019 Jul 25. pii: 5538868. doi: 10.1093.
    >> Share

  311. CICCONI P, Jones C, Sarkar E, Reyes LS, et al
    First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.
    Clin Infect Dis. 2019 Jul 24. pii: 5537685. doi: 10.1093.
    >> Share

  312. KORSTEN K, Bont LJ
    Sustained cellular and humoral immune responses from an adenoviral vector-based RSV vaccine.
    Clin Infect Dis. 2019 Jul 24. pii: 5537713. doi: 10.1093.
    >> Share

  313. KHAGAYI S, Omore R, Otieno GP, Ogwel B, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.
    Clin Infect Dis. 2019 Jul 20. pii: 5536640. doi: 10.1093.
    >> Share

  314. OEHLER RL
    On Measles, Vaccination, Social Media Activism and How to Win Back Our Role as our Patients' Best Advocates.
    Clin Infect Dis. 2019 Jul 15. pii: 5532609. doi: 10.1093.
    >> Share

  315. MISCHLINGER J, Muranaka R, Buhler S, Ramharter M, et al
    Measles, vaccines and types of perception bias in public debates.
    Clin Infect Dis. 2019 Jul 12. pii: 5531659. doi: 10.1093.
    >> Share

    June 2019
  316. FERDINANDS JM, Alyanak E, Reed C, Fry AM, et al
    Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults.
    Clin Infect Dis. 2019 Jun 29. pii: 5525379. doi: 10.1093.
    >> Share

  317. KLEIN NP, Fireman B
    If Influenza Vaccines Wane Can We Delay Vaccination Without Compromising Coverage?
    Clin Infect Dis. 2019 Jun 29. pii: 5525380. doi: 10.1093.
    >> Share

  318. YAN D, Wang D, Zhu S, Zhang Y, et al
    Immunogenicity of oral polio vaccine and Salk inactive polio vaccine against Xinjiang imported type 1 wild poliovirus.
    Clin Infect Dis. 2019 Jun 25. pii: 5523198. doi: 10.1093.
    >> Share

  319. DANANCHE C, Paranhos-Baccala G, Messaoudi M, Sylla M, et al
    Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized With or Without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study.
    Clin Infect Dis. 2019 Jun 25. pii: 5522937. doi: 10.1093.
    >> Share

  320. KING H, Xing J, Dean HD, Holtzman D, et al
    Trends in prevalence of protective levels of hepatitis B surface antibody among adults aged 18-49 years with risk factors for hepatitis B virus infection-United States, 2003-2014.
    Clin Infect Dis. 2019 Jun 20. pii: 5522094. doi: 10.1093.
    >> Share

  321. BLYTH CC, Jayasinghe S, Andrews RM
    A rationale for change: an increase in Invasive Pneumococcal Disease in fully vaccinated children.
    Clin Infect Dis. 2019 Jun 18. pii: 5519836. doi: 10.1093.
    >> Share

  322. RAY GT, Lewis N, Fireman B
    Reply to Ferdinands et al.
    Clin Infect Dis. 2019;69:191-192.
    >> Share

  323. YILDIRIM I, Pelton SI
    Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era.
    Clin Infect Dis. 2019;69:91-92.
    >> Share

  324. GROENEVELD GH, Wijn DH, Vollaard AM
    Immune related adverse events in cancer patients receiving influenza vaccination and immune checkpoint inhibitors.
    Clin Infect Dis. 2019 Jun 17. pii: 5519876. doi: 10.1093.
    >> Share

  325. TURNER P, Leab P, Ly S, Sao S, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonisation and Invasive Disease in Cambodian Children.
    Clin Infect Dis. 2019 Jun 7. pii: 5512979. doi: 10.1093.
    >> Share

  326. MURDOCH DR
    Assessing the Impact of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019 Jun 7. pii: 5512963. doi: 10.1093.
    >> Share

  327. LIN KY, Sun HY, Chen YH, Lo YC, et al
    Effect of a hepatitis A vaccination campaign during a hepatitis A outbreak in Taiwan, 2015-2017: a modeling study.
    Clin Infect Dis. 2019 Jun 3. pii: 5510337. doi: 10.1093.
    >> Share

    May 2019
  328. GROOME MJ, Tate JE, Arnold M, Chitnis M, et al
    Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.
    Clin Infect Dis. 2019 May 24. pii: 5498228. doi: 10.1093.
    >> Share

  329. KITCHIN N, Remich SA, Peterson J, Peng Y, et al
    A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
    Clin Infect Dis. 2019 May 24. pii: 5498282. doi: 10.1093.
    >> Share


  330. Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans.
    Clin Infect Dis. 2019 May 23. pii: 5497806. doi: 10.1093.
    >> Share

  331. MONTO AS, Petrie JG
    Improving influenza vaccine effectiveness: ways to begin solving the problem.
    Clin Infect Dis. 2019 May 17. pii: 5491466. doi: 10.1093.
    >> Share

  332. BELONGIA EA, McLean HQ
    Influenza Vaccine Effectiveness: Defining the H3N2 Problem.
    Clin Infect Dis. 2019 May 17. pii: 5491465. doi: 10.1093.
    >> Share

  333. CHAGUZA C, Heinsbroek E, Gladstone RA, Tafatatha T, et al
    Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data.
    Clin Infect Dis. 2019 May 16. pii: 5490137. doi: 10.1093.
    >> Share

  334. JALLOW S, Wilmshurst JM, Howard W, Copelyn J, et al
    Accelerated immunodeficiency-associated vaccine derived poliovirus serotype 3 (iVDPV3) sequence evolution rate in a 3-month old boy with X-linked agammaglobulinemia and perinatal HIV exposure.
    Clin Infect Dis. 2019 May 14. pii: 5489041. doi: 10.1093.
    >> Share

  335. PIERROTTI LC, Duarte-Neto AN, Song ATW, Ventura CG, et al
    Fatal Yellow Fever in a kidney transplant patient.
    Clin Infect Dis. 2019 May 11. pii: 5488071. doi: 10.1093.
    >> Share

  336. CARVALHO CFA, Andrews N, Dabrera G, Ribeiro S, et al
    National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.
    Clin Infect Dis. 2019 May 6. pii: 5486166. doi: 10.1093.
    >> Share

  337. SKOWRONSKI DM, De Serres G
    Evidence in a cluster randomized controlled trial of increased 2009 pandemic risk associated with 2008-09 seasonal influenza vaccine receipt.
    Clin Infect Dis. 2019 May 6. pii: 5485848. doi: 10.1093.
    >> Share

  338. MATRAJT L, Halloran ME, Antia R
    Successes and failures of the live-attenuated influenza vaccine: can we do better?
    Clin Infect Dis. 2019 May 6. pii: 5485903. doi: 10.1093.
    >> Share

    April 2019
  339. WOLFSON LJ, Daniels VJ, Altland A, Black W, et al
    The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.
    Clin Infect Dis. 2019 Apr 24. pii: 5477436. doi: 10.1093.
    >> Share

  340. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
    Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
    Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
    >> Share

  341. LINDHOLM DA, Fisher RD, Montgomery JR, Davidson W, et al
    Preemptive Tecovirimat Use in an Active Duty Member Presenting with Acute Myeloid Leukemia after Smallpox Vaccination.
    Clin Infect Dis. 2019 Apr 9. pii: 5432316. doi: 10.1093.
    >> Share

  342. STEENS A, Winje BA, White RA, Odsbu I, et al
    Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study.
    Clin Infect Dis. 2019;68:1367-1373.
    >> Share

  343. KELLNER JD
    Who Benefits, and How Much? Indirect Effects of Childhood Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease.
    Clin Infect Dis. 2019;68:1374-1375.
    >> Share

  344. MEMOLI MJ, Han A, Walters KA, Czajkowski L, et al
    Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
    Clin Infect Dis. 2019 Apr 6. pii: 5429562. doi: 10.1093.
    >> Share

  345. HARRIMAN K, Healy CM
    How Important Is the Type of Acellular Pertussis Vaccine?
    Clin Infect Dis. 2019 Apr 5. pii: 5486164. doi: 10.1093.
    >> Share

    March 2019
  346. LE ROUX DM, Nicol MP, Myer L, Vanker A, et al
    Lower Respiratory Tract Infections in Children in a Well-vaccinated South African Birth Cohort: Spectrum of Disease and Risk Factors.
    Clin Infect Dis. 2019 Mar 29. pii: 5423418. doi: 10.1093.
    >> Share

  347. LU CY, Chiang CS, Chiu CH, Wang ET, et al
    Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan.
    Clin Infect Dis. 2019 Mar 28. pii: 5421736. doi: 10.1093/cid/ciy1127.
    >> Share

  348. BLOK BA, de Bree LCJ, Diavatopoulos DA, Langereis JD, et al
    INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL.
    Clin Infect Dis. 2019 Mar 28. pii: 5421296. doi: 10.1093.
    >> Share

  349. VAN AALST M, Garrido HMG, van der Leun J, Meek B, et al
    Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease.
    Clin Infect Dis. 2019 Mar 22. pii: 5418537. doi: 10.1093.
    >> Share

  350. VERDOODT F, Dehlendorff C, Kjaer SK
    Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study.
    Clin Infect Dis. 2019 Mar 20. pii: 5403490. doi: 10.1093.
    >> Share

  351. ROMANIN V, Acosta AM, Juarez MDV, Briere E, et al
    Maternal Vaccination in Argentina: Tdap Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants Less Than 2 Months of Age.
    Clin Infect Dis. 2019 Mar 16. pii: 5381906. doi: 10.1093.
    >> Share

  352. CHONG CR, Park VJ, Cohen B, Postow MA, et al
    Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors (ICI).
    Clin Infect Dis. 2019 Mar 15. pii: 5381697. doi: 10.1093.
    >> Share

  353. LEVY C, Varon E, Ouldali N, Bechet S, et al
    Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation.
    Clin Infect Dis. 2019 Mar 14. pii: 5380638. doi: 10.1093.
    >> Share

  354. COLIN-JONES R, Shakya M, Voysey M, Theiss-Nyland K, et al
    Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.
    Clin Infect Dis. 2019;68.
    >> Share

  355. LUTHRA K, Watts E, Debellut F, Pecenka C, et al
    A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
    Clin Infect Dis. 2019;68.
    >> Share

  356. THEISS-NYLAND K, Qadri F, Colin-Jones R, Zaman K, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Clin Infect Dis. 2019;68.
    >> Share

  357. LAURENS MB, Sirima SB, Rotrosen ET, Siribie M, et al
    A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Clin Infect Dis. 2019;68.
    >> Share

  358. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2019;68.
    >> Share

  359. JAMKA LP, Simiyu KW, Bentsi-Enchill AD, Mwisongo AJ, et al
    Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
    Clin Infect Dis. 2019;68.
    >> Share

  360. LIU X, Pitzer VE, Pollard AJ, Voysey M, et al
    The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines.
    Clin Infect Dis. 2019;68.
    >> Share

  361. SAHA S, Islam MS, Sajib MSI, Saha S, et al
    Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy.
    Clin Infect Dis. 2019;68.
    >> Share

  362. KAUFHOLD S, Yaesoubi R, Pitzer VE
    Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.
    Clin Infect Dis. 2019;68.
    >> Share

  363. MEIRING JE, Sambakunsi R, Moyo E, Misiri T, et al
    Community Engagement Before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons.
    Clin Infect Dis. 2019;68.
    >> Share

  364. DEBELLUT F, Hendrix N, Pitzer VE, Neuzil KM, et al
    Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.
    Clin Infect Dis. 2019;68.
    >> Share

  365. MEIRING JE, Laurens MB, Patel P, Patel P, et al
    Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Clin Infect Dis. 2019;68.
    >> Share

  366. VINK P, Ramon Torrell JM, Sanchez Fructuoso A, Kim SJ, et al
    Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: a Phase III, Randomized Clinical Trial.
    Clin Infect Dis. 2019 Mar 7. pii: 5370445. doi: 10.1093.
    >> Share

  367. MILLER G
    Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens.
    Clin Infect Dis. 2019 Mar 7. pii: 5370442. doi: 10.1093.
    >> Share

  368. HANSSON K, Rosdahl A, Insulander M, Vene S, et al
    Tick-borne encephalitis (TBE) vaccine failures: A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years.
    Clin Infect Dis. 2019 Mar 7. pii: 5370446. doi: 10.1093.
    >> Share

    February 2019
  369. MOSCICKI AB, Karalius B, Tassiopoulos K, Yao TJ, et al
    Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
    Clin Infect Dis. 2019 Feb 21. pii: 5423927. doi: 10.1093/cid/ciy1040.
    >> Share

  370. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Seroprotection at different levels of the health care system after routine vaccination with DTPw-HepB-Hib in Lao PDR.
    Clin Infect Dis. 2019 Feb 19. pii: 5335760. doi: 10.1093.
    >> Share

  371. CHURCH JA, Rukobo S, Govha M, Lee B, et al
    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
    Clin Infect Dis. 2019 Feb 16. pii: 5321771. doi: 10.1093.
    >> Share

  372. WIESE AD, Huang X, Yu C, Mitchel EF, et al
    Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.
    Clin Infect Dis. 2019 Feb 16. pii: 5321113. doi: 10.1093.
    >> Share

  373. BIGOGO GM, Audi A, Auko J, Aol GO, et al
    Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Clin Infect Dis. 2019 Feb 16. pii: 5346100. doi: 10.1093.
    >> Share

  374. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    >> Share

  375. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    >> Share

  376. YOUSAFZAI MT, Qamar FN, Shakoor S, Saleem K, et al
    Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2019;68.
    >> Share

  377. SAHASTRABUDDHE S, Saluja T
    Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Clin Infect Dis. 2019;68.
    >> Share

  378. BENTSI-ENCHILL AD, Hombach J
    Revised Global Typhoid Vaccination Policy.
    Clin Infect Dis. 2019;68.
    >> Share

  379. CRUMP JA
    Progress in Typhoid Fever Epidemiology.
    Clin Infect Dis. 2019;68.
    >> Share

  380. CAREY ME, Diaz ZI, Zaidi AKM, Steele AD, et al
    A Global Agenda for Typhoid Control-A Perspective from the Bill & Melinda Gates Foundation.
    Clin Infect Dis. 2019;68.
    >> Share

  381. LINDSAY S, Garrett D, Steele D
    Evidence to Action: The 10th International Conference on Typhoid and Other Invasive Salmonelloses.
    Clin Infect Dis. 2019;68.
    >> Share

  382. STEELE AD, Parashar UD
    Rotavirus Vaccines set to make inroads in Asia.
    Clin Infect Dis. 2019 Feb 13. pii: 5316811. doi: 10.1093.
    >> Share

  383. SCHWARTZ LM, Zaman K, Yunus M, Basunia AH, et al
    Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.
    Clin Infect Dis. 2019 Feb 12. pii: 5316286. doi: 10.1093.
    >> Share

  384. DESTEFANO F, Bodenstab HM, Offit PA
    Principal Controversies in Vaccine Safety in the United States.
    Clin Infect Dis. 2019 Feb 12. pii: 5316263. doi: 10.1093.
    >> Share

  385. SEGALOFF HE, Leventer-Roberts M, Riesel D, Malosh RE, et al
    Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18.
    Clin Infect Dis. 2019 Feb 11. pii: 5314854. doi: 10.1093.
    >> Share

  386. SKOWRONSKI DM, De Serres G, Orenstein WA
    Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.
    Clin Infect Dis. 2019 Feb 7. pii: 5308623. doi: 10.1093.
    >> Share

  387. ROLFES MA, Flannery B, Chung J, O'Halloran A, et al
    Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season.
    Clin Infect Dis. 2019 Feb 2. pii: 5305915. doi: 10.1093.
    >> Share

  388. NEUZIL KM, Fitzpatrick MC
    The Impact of Influenza Vaccine: It's the Size of the Glass.
    Clin Infect Dis. 2019 Feb 2. pii: 5306034. doi: 10.1093.
    >> Share

  389. KOREM M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, et al
    Intensive care admissions and associated severity of influenza B versus A during influenza B-vaccine mismatched seasons.
    Clin Infect Dis. 2019 Feb 1. pii: 5305596. doi: 10.1093.
    >> Share

    January 2019
  390. HASSO-AGOPSOWICZ M, Ladva CN, Lopman B, Sanderson C, et al
    Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.
    Clin Infect Dis. 2019 Jan 28. pii: 5303786. doi: 10.1093.
    >> Share

  391. DIALLO A, Diop OM, Diop D, Niang MN, et al
    Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.
    Clin Infect Dis. 2019 Jan 28. pii: 5303780. doi: 10.1093.
    >> Share

  392. GREENWOOD B
    Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination.
    Clin Infect Dis. 2019;68:444-445.
    >> Share

  393. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    >> Share

  394. VEKEMANS J, Gouvea-Reis F, Kim JH, Excler JL, et al
    The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics.
    Clin Infect Dis. 2019 Jan 8. pii: 5280612. doi: 10.1093/cid/ciy1143.
    >> Share

  395. BONOMO ME, Deem MW
    Reply to Xu and Ye: On the Sufficiency of the Pepitope Method.
    Clin Infect Dis. 2019;68:347.
    >> Share

  396. MBALA-KINGEBENI P, Villabona-Arenas CJ, Vidal N, Likofata J, et al
    Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Clin Infect Dis. 2019;68:330-333.
    >> Share

  397. ASNER SA, Agyeman PKA, Gradoux E, Posfay-Barbe KM, et al
    Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.
    Clin Infect Dis. 2019 Jan 2. pii: 5270128. doi: 10.1093/cid/ciy1139.
    >> Share

    December 2018
  398. HARDER T, Siedler A
    Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the "exogenous boosting hypothesis".
    Clin Infect Dis. 2018 Dec 24. pii: 5258112. doi: 10.1093/cid/ciy1099.
    >> Share

  399. MUJURU HA, Burnett E, Nathoo KJ, Ticklay I, et al
    Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.
    Clin Infect Dis. 2018 Dec 23. pii: 5258061. doi: 10.1093/cid/ciy1096.
    >> Share

  400. MEHANNA H, Bryant TS, Babrah J, Louie K, et al
    Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study.
    Clin Infect Dis. 2018 Dec 22. pii: 5257796. doi: 10.1093/cid/ciy1081.
    >> Share

  401. SOENTJENS P, De Koninck K, Tsoumanis A, Herssens N, et al
    A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
    Clin Infect Dis. 2018 Dec 19. pii: 5253211. doi: 10.1093.
    >> Share

  402. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    >> Share

  403. POLLOCK L, Bennett A, Jere KC, Dube Q, et al
    Non-secretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants.
    Clin Infect Dis. 2018 Dec 18. pii: 5252030. doi: 10.1093/cid/ciy1067.
    >> Share

  404. FERDINANDS JM, Patel MM, Foppa IM, Fry AM, et al
    Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Dec 18. pii: 5251717. doi: 10.1093/cid/ciy1084.
    >> Share

  405. CHEN H, Alvarez JJS, Ng SH, Nielsen R, et al
    Passage adaptation correlates with the reduced efficacy of the influenza vaccine.
    Clin Infect Dis. 2018 Dec 18. pii: 5252062. doi: 10.1093/cid/ciy1065.
    >> Share

  406. GILBERT L, Wang X, Deiss R, Okulicz J, et al
    Herpes Zoster Rates Continue to Decline in People Living with HIV but Remain Higher than Rates Reported in the General US Population.
    Clin Infect Dis. 2018 Dec 18. pii: 5251723. doi: 10.1093/cid/ciy1041.
    >> Share

  407. SEMCHENKO EA, Tan A, Borrow R, Seib KL, et al
    The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae.
    Clin Infect Dis. 2018 Dec 14. pii: 5247042. doi: 10.1093/cid/ciy1061.
    >> Share

  408. NICHOLS MK, Andrew MK, Ye L, Hatchette TF, et al
    The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.
    Clin Infect Dis. 2018 Dec 3. pii: 5228721. doi: 10.1093/cid/ciy1009.
    >> Share

    November 2018
  409. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children.
    Clin Infect Dis. 2018 Nov 29. pii: 5213086. doi: 10.1093.
    >> Share

  410. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults.
    Clin Infect Dis. 2018 Nov 29. pii: 5213085. doi: 10.1093.
    >> Share

  411. BRICKLEY EB, Wright PF, Khalenkov A, Neuzil KM, et al
    The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.
    Clin Infect Dis. 2018 Nov 27. pii: 5210472. doi: 10.1093/cid/ciy1004.
    >> Share

  412. LEWIS KDC, Ortiz JR, Rahman MZ, Levine MZ, et al
    Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh.
    Clin Infect Dis. 2018 Nov 27. pii: 5210460. doi: 10.1093/cid/ciy1003.
    >> Share

  413. GANMAA D, Khudyakov P, Buyanjargal U, Jargalsaikhan B, et al
    Prevalence and determinants of QuantiFERON-diagnosed tuberculosis infection in 9,810 Mongolian schoolchildren.
    Clin Infect Dis. 2018 Nov 27. pii: 5210883. doi: 10.1093.
    >> Share

  414. MCHUGH L, Marshall HS, Perrett KP, Nolan T, et al
    The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
    Clin Infect Dis. 2018 Nov 23. pii: 5202330. doi: 10.1093.
    >> Share

  415. KOLDITZ M, Schmitt J, Pletz MW, Tesch F, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged >/= 60 years - a population-based retrospective cohort study.
    Clin Infect Dis. 2018 Nov 21. pii: 5194155. doi: 10.1093.
    >> Share

  416. CHU V, Carpenter DM, Winter K, Harriman K, et al
    Increased risk of late-onset Streptococcus pneumoniae meningitis in adults with prior head or spine surgeries.
    Clin Infect Dis. 2018 Nov 19. pii: 5191692. doi: 10.1093.
    >> Share

  417. LOEVINSOHN G, Rosman L, Moss WJ
    Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review.
    Clin Infect Dis. 2018 Nov 17. pii: 5188002. doi: 10.1093.
    >> Share

  418. MUTSAERTS EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al
    Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
    Clin Infect Dis. 2018 Nov 12. pii: 5174340. doi: 10.1093.
    >> Share

    October 2018
  419. ALTAMIRANO J, Purington N, Behl R, Sarnquist C, et al
    Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
    Clin Infect Dis. 2018;67.
    >> Share

  420. GAENSBAUER JT, Gast C, Bandyopadhyay AS, O'Ryan M, et al
    Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
    Clin Infect Dis. 2018;67.
    >> Share

  421. ALTAMIRANO J, Leary S, van Hoorebeke C, Sarnquist C, et al
    Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Clin Infect Dis. 2018;67.
    >> Share

  422. VAN HOOREBEKE C, Huang C, Leary S, Holubar M, et al
    Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
    Clin Infect Dis. 2018;67.
    >> Share

  423. BHAUMIK SK, Kulkarni RR, Weldon WC, Silveira ELV, et al
    Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.
    Clin Infect Dis. 2018;67.
    >> Share

  424. JARVIS CI, Altamirano J, Sarnquist C, Edmunds WJ, et al
    Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
    Clin Infect Dis. 2018;67.
    >> Share

  425. RESIK S, Tejeda A, Mach O, Fonseca M, et al
    Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
    Clin Infect Dis. 2018;67.
    >> Share

  426. FU R, Altamirano J, Sarnquist CC, Maldonado YA, et al
    Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.
    Clin Infect Dis. 2018;67.
    >> Share

  427. BRICKLEY EB, Wieland-Alter W, Connor RI, Ackerman ME, et al
    Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chil
    Clin Infect Dis. 2018;67.
    >> Share

  428. ALTAMIRANO J, Sarnquist C, Behl R, Garcia-Garcia L, et al
    OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Clin Infect Dis. 2018;67.
    >> Share

  429. SARNQUIST C, Holubar M, Garcia-Garcia L, Ferreyra-Reyes L, et al
    Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Clin Infect Dis. 2018;67.
    >> Share

  430. HALPERN MS, Altamirano J, Maldonado Y
    Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Clin Infect Dis. 2018;67.
    >> Share

  431. BANDYOPADHYAY AS, Modlin JF, Wenger J, Gast C, et al
    Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Clin Infect Dis. 2018;67.
    >> Share

  432. DANINO D, Givon-Lavi N, Ben-Shimol S, Greenberg D, et al
    Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.
    Clin Infect Dis. 2018 Oct 29. pii: 5146358. doi: 10.1093.
    >> Share

  433. HAVERS FP, Chung JR, Belongia EA, McLean HQ, et al
    Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.
    Clin Infect Dis. 2018 Oct 27. pii: 5145968. doi: 10.1093.
    >> Share

  434. SINGS HL, De Wals P, Gessner BD, Isturiz R, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies.
    Clin Infect Dis. 2018 Oct 23. pii: 5142858. doi: 10.1093.
    >> Share

  435. LOPEZ BERNAL JA, Andrews N, Amirthalingam G
    The use of quasi-experimental designs for vaccine evaluation.
    Clin Infect Dis. 2018 Oct 22. pii: 5140188. doi: 10.1093.
    >> Share

  436. PRAHARAJ I, Platts-Mills JA, Taneja S, Antony K, et al
    Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India.
    Clin Infect Dis. 2018 Oct 17. pii: 5134205. doi: 10.1093.
    >> Share

  437. SMITS G, Stabell Benn C, Whittle H, van Binnendijk R, et al
    Maternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.
    Clin Infect Dis. 2018 Oct 16. pii: 5133427. doi: 10.1093.
    >> Share

  438. WEINBERGER DM, Shapiro ED
    Prevention of Pneumococcal Infections in Adults using Conjugate Vaccines: No Easy Answers.
    Clin Infect Dis. 2018 Oct 12. pii: 5127383. doi: 10.1093.
    >> Share

  439. VADLAMUDI NK, Chen A, Marra F
    Impact of 13-pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis.
    Clin Infect Dis. 2018 Oct 12. pii: 5127380. doi: 10.1093.
    >> Share

  440. HYLE EP, Fields NF, Fiebelkorn AP, Walker AT, et al
    The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers.
    Clin Infect Dis. 2018 Oct 11. pii: 5127132. doi: 10.1093.
    >> Share

  441. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
    Clin Infect Dis. 2018 Oct 11. pii: 5127119. doi: 10.1093.
    >> Share

  442. THOMPSON MG, Kwong JC, Regan AK, Katz MA, et al
    Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Clin Infect Dis. 2018 Oct 11. pii: 5126390. doi: 10.1093.
    >> Share

  443. MUNOZ FM
    Influenza Vaccination During Pregnancy Can Protect Women Against Hospitalization Across Continents.
    Clin Infect Dis. 2018 Oct 11. pii: 5126392. doi: 10.1093.
    >> Share

  444. HILLIER SL, Ferrieri P, Edwards MS, Ewell M, et al
    A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III.
    Clin Infect Dis. 2018 Oct 3. pii: 5114388. doi: 10.1093.
    >> Share

  445. YOUNG B, Sadarangani S, Sen Yew H, Yung CF, et al
    Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial.
    Clin Infect Dis. 2018 Oct 1. pii: 5113434. doi: 10.1093.
    >> Share

    September 2018
  446. WANG W, Chen Q, Ford-Siltz LA, Katzelnick LC, et al
    Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains after Vaccination with Inactivated Trivalent Influenza Vaccine Vary with Age and Prior Year Vaccination.
    Clin Infect Dis. 2018 Sep 25. pii: 5106972. doi: 10.1093.
    >> Share

  447. GIBANI MM, Voysey M, Jin C, Jones C, et al
    The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Clin Infect Dis. 2018 Sep 25. pii: 5106547. doi: 10.1093.
    >> Share

  448. LEE RU, Phillips CJ, Faix DJ
    Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy.
    Clin Infect Dis. 2018 Sep 20. pii: 5104116. doi: 10.1093.
    >> Share

  449. PINANA JL, Perez A, Montoro J, Gimenez E, et al
    Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: A cross-sectional prospective observational study.
    Clin Infect Dis. 2018 Sep 15. pii: 5098399. doi: 10.1093.
    >> Share

  450. FLANNERY B, Chung JR, Monto AS, Martin ET, et al
    Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season.
    Clin Infect Dis. 2018 Sep 11. pii: 5094815. doi: 10.1093.
    >> Share

  451. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Sep 10. pii: 5094689. doi: 10.1093.
    >> Share

  452. LIPSITCH M
    Challenges of vaccine effectiveness and waning studies.
    Clin Infect Dis. 2018 Sep 10. pii: 5094713. doi: 10.1093.
    >> Share

  453. CHEN LH, Kozarsky PE, Visser LG
    What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.
    Clin Infect Dis. 2018 Sep 10. pii: 5094712. doi: 10.1093.
    >> Share

  454. COWLING BJ, Lim WW, Perera RAPM, Fang VJ, et al
    Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.
    Clin Infect Dis. 2018 Sep 8. pii: 5092748. doi: 10.1093.
    >> Share

  455. POMAT WS, van den Biggelaar AHJ, Wana S, Greenhill AR, et al
    Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.
    Clin Infect Dis. 2018 Sep 3. pii: 5089945. doi: 10.1093.
    >> Share

    August 2018
  456. USUF E, Bottomley C, Bojang E, Cox I, et al
    Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of non-vaccine serotypes among vaccinated infants and their mothers five years after PCV13 introduction in The Gambia.
    Clin Infect Dis. 2018 Aug 24. pii: 5079135. doi: 10.1093.
    >> Share

  457. GARGANO JW, Park IU, Griffin MR, Niccolai LM, et al
    Trends in High-grade Cervical Lesions and Cervical Cancer Screening in Five States, 2008-2015.
    Clin Infect Dis. 2018 Aug 23. pii: 5078164. doi: 10.1093.
    >> Share

  458. BLYTH CC, Macartney KK, McRae J, Clark JE, et al
    Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.
    Clin Infect Dis. 2018 Aug 21. pii: 5077025. doi: 10.1093.
    >> Share

    July 2018
  459. YARO S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, et al
    Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
    Clin Infect Dis. 2018 Jul 26. pii: 5059984. doi: 10.1093.
    >> Share

  460. BLANCHARD ROHNER G, Chatzis O, Chinwangso P, Rohr M, et al
    Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jul 26. pii: 5059783. doi: 10.1093.
    >> Share

  461. PETOUSIS-HARRIS H, Howe AS, Janine P, Turner N, et al
    Pneumococcal conjugate vaccines turning the tide on inequity - a retrospective cohort study of New Zealand children born 2006-2015.
    Clin Infect Dis. 2018 Jul 19. pii: 5055833. doi: 10.1093.
    >> Share

  462. BAKER JM, Tate JE, Steiner CA, Haber MJ, et al
    Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.
    Clin Infect Dis. 2018 Jul 18. pii: 5055445. doi: 10.1093.
    >> Share

  463. HALPERIN SA, Langley JM, Ye L, MacKinnon-Cameron D, et al
    A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Clin Infect Dis. 2018 Jul 13. pii: 5053576. doi: 10.1093.
    >> Share

  464. XU Y, Ye J
    Predicting influenza vaccine effectiveness with hemagglutinin sequences is not sufficient enough.
    Clin Infect Dis. 2018 Jul 9. pii: 5050680. doi: 10.1093.
    >> Share

  465. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    >> Share

    June 2018
  466. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    >> Share

  467. SOENTJENS P, Andries P, Aerssens A, Tsoumanis A, et al
    Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
    Clin Infect Dis. 2018 Jun 25. pii: 5043520. doi: 10.1093.
    >> Share

  468. TRIEU MC, Jul-Larsen A, Saevik M, Madsen A, et al
    Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a five-year follow-up study.
    Clin Infect Dis. 2018 Jun 9. pii: 5035295. doi: 10.1093.
    >> Share

  469. CHERRY JD, Zahn M
    Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California.
    Clin Infect Dis. 2018 Jun 7. pii: 5034094. doi: 10.1093.
    >> Share

  470. MOSS W
    Measles in Vaccinated Individuals and the Future of Measles Elimination.
    Clin Infect Dis. 2018 Jun 7. pii: 5034071. doi: 10.1093.
    >> Share

  471. KILMER GA, Barker LK, Ly KN, Jiles RB, et al
    Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015.
    Clin Infect Dis. 2018 Jun 1. pii: 5026244. doi: 10.1093.
    >> Share

    May 2018
  472. SORUP S, Jensen AKG, Aaby P, Benn CS, et al
    Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
    Clin Infect Dis. 2018 May 26. pii: 5005938. doi: 10.1093.
    >> Share

  473. MCLAUGHLIN JM, Jiang Q, Isturiz RE, Sings HL, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    Clin Infect Dis. 2018 May 21. pii: 5000157. doi: 10.1093.
    >> Share

  474. LANGEDIJK AC, de Pijper CA, Spijker R, Holman R, et al
    Rabies Antibody Response after Booster Immunization: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2018 May 17. pii: 4996990. doi: 10.1093.
    >> Share

  475. BURKE RM, Tate JE, Dahl RM, Aliabadi N, et al
    Rotavirus Vaccination Is Associated with Reduced Seizure Hospitalization Risk Among Commercially Insured U.S. Children.
    Clin Infect Dis. 2018 May 16. pii: 4996816. doi: 10.1093.
    >> Share

    April 2018
  476. CASADEVALL A, Pirofski LA
    A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis.
    Clin Infect Dis. 2018 Apr 25. pii: 4984538. doi: 10.1093.
    >> Share

  477. EDWARDS JE JR, Schwartz MM, Schmidt CS, Sobel JD, et al
    A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2018 Apr 25. pii: 4984537. doi: 10.1093.
    >> Share

  478. SKOWRONSKI DM, De Serres G
    Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season.
    Clin Infect Dis. 2018 Apr 24. pii: 4983050. doi: 10.1093.
    >> Share

  479. KOSIKOVA M, Li L, Radvak P, Ye Z, et al
    Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
    Clin Infect Dis. 2018 Apr 17. pii: 4972882. doi: 10.1093.
    >> Share

  480. BONOMO ME, Deem MW
    Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope.
    Clin Infect Dis. 2018 Apr 17. pii: 4972858. doi: 10.1093.
    >> Share

  481. WILKIN TJ, Chen H, Cespedes MS, Leon-Cruz JT, et al
    A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298.
    Clin Infect Dis. 2018 Apr 5. pii: 4961357. doi: 10.1093.
    >> Share

    March 2018
  482. SIGURETHSSON S, Eythorsson E, Hrafnkelsson B, Erlendsdottir H, et al
    Reduction in all-cause acute otitis media in children less than three years of age in primary care following pneumococcal vaccination with PHiD-CV10: A whole population study.
    Clin Infect Dis. 2018 Mar 30. pii: 4956759. doi: 10.1093.
    >> Share

  483. HANSON KE, Koch B, Bonner K, McRee AL, et al
    National Trends in Parental HPV Vaccination Intentions and Reasons for Hesitancy, 2010-2015.
    Clin Infect Dis. 2018 Mar 27. pii: 4955216. doi: 10.1093.
    >> Share

  484. BENSON CA, Andersen JW, Macatangay BJC, Mailliard RB, et al
    Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 26. pii: 4953774. doi: 10.1093.
    >> Share

  485. DE SERRES G, Skowronski DM
    Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.
    Clin Infect Dis. 2018 Mar 21. pii: 4948704. doi: 10.1093.
    >> Share

  486. SAITO N, Komori K, Suzuki M, Kishikawa T, et al
    Dose-Dependent Negative Effects of Prior Multiple Vaccinations against Influenza A and Influenza B among School Children: A Study of Kamigoto Island in Japan during the 2011/12, 2012/13 and 2013/14 Influenza Seasons.
    Clin Infect Dis. 2018 Mar 8. pii: 4924693. doi: 10.1093.
    >> Share

    February 2018
  487. COBEY S, Gouma S, Parkhouse K, Chambers BS, et al
    Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.
    Clin Infect Dis. 2018 Feb 20. pii: 4846904. doi: 10.1093.
    >> Share

  488. ANDERSON EJ, Daugherty MA, Pickering LK, Orenstein WA, et al
    Protecting the Community through Child Vaccination.
    Clin Infect Dis. 2018 Feb 17. pii: 4868144. doi: 10.1093.
    >> Share

  489. JAYASINGHE S, Chiu C, Quinn H, Menzies R, et al
    Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study.
    Clin Infect Dis. 2018 Feb 17. pii: 4868133. doi: 10.1093.
    >> Share


  490. Philippines Says Anti-Dengue Vaccine may be Connected to Three Deaths.
    Clin Infect Dis. 2018 Feb 17. pii: 4868143. doi: 10.1093.
    >> Share

  491. WHITNEY CG
    Examining Duration of Protection: should a Booster dose be Part of all Infant Pneumococcal Conjugate Vaccine Programs?
    Clin Infect Dis. 2018 Feb 17. pii: 4868134. doi: 10.1093.
    >> Share

  492. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal.
    Clin Infect Dis. 2018 Feb 14. pii: 4857181. doi: 10.1093.
    >> Share

  493. IZURIETA HS, Chillarige Y, Kelman JA, Forshee R, et al
    Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015.
    Clin Infect Dis. 2018 Feb 9. pii: 4846330. doi: 10.1093.
    >> Share

  494. SUZUKI M, Saito N
    Influenza vaccine effectiveness and age.
    Clin Infect Dis. 2018 Feb 7. pii: 4841718. doi: 10.1093.
    >> Share

    January 2018
  495. VOYSEY M, Pollard AJ
    Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV).
    Clin Infect Dis. 2018 Jan 17. pii: 4815743. doi: 10.1093/cid/cix1145.
    >> Share

  496. BURGNER DP, Miller JE, Strunk T, Nassar N, et al
    Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections.
    Clin Infect Dis. 2018;66:318-319.
    >> Share

  497. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
    Clin Infect Dis. 2018 Jan 6. pii: 4792029. doi: 10.1093.
    >> Share

    December 2017
  498. SIMMONS G, Stone M, Busch MP
    Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.
    Clin Infect Dis. 2017 Dec 30. pii: 4760439. doi: 10.1093.
    >> Share

  499. PLENNEVAUX E, Moureau A, Arredondo-Garcia JL, Villar L, et al
    Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
    Clin Infect Dis. 2017 Dec 30. pii: 4782289. doi: 10.1093.
    >> Share

  500. CHONG PP, Handler L, Weber DJ
    A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743238. doi: 10.1093/cid/cix1081.
    >> Share

  501. NATORI Y, Shiotsuka M, Slomovic J, Hoschler K, et al
    A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743251. doi: 10.1093/cid/cix1082.
    >> Share

    November 2017
  502. LOPEZ AL, Deen J, Azman AS, Luquero FJ, et al
    Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Nov 21. pii: 4645296. doi: 10.1093/cid/cix1039.
    >> Share

  503. FISKER AB, Nebie E, Schoeps A, Martins C, et al
    A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
    Clin Infect Dis. 2017 Nov 21. pii: 4645294. doi: 10.1093/cid/cix1033.
    >> Share

  504. YE S, Whiley DM, Ware RS, Kirkwood CD, et al
    Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093/cid/cix1022.
    >> Share

  505. STEIN Y, Mandelboim M, Sefty H, Pando R, et al
    Seasonal influenza vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in Israel 2016-2017 season: insights into novel age-specific analysis.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1013.
    >> Share

  506. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    >> Share

  507. LAWN JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, et al
    Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
    Clin Infect Dis. 2017;65.
    >> Share

    October 2017
  508. FATHIMA P, Blyth CC, Lehmann D, Lim FJ, et al
    The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469,589 births (1996-2012).
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    >> Share

  509. TAM YH, Valkenburg SA, Perera RAPM, Wong JHF, et al
    Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    >> Share

  510. POEHLING KA, Caspard H, Peters TR, Belongia EA, et al
    2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

  511. ORTIZ JR
    The challenge of vaccine policy-making with imperfect data.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

  512. KJAER SK, Nygard M, Dillner J, Brooke Marshall J, et al
    A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
    Clin Infect Dis. 2017 Oct 1. doi: 10.1093.
    >> Share

  513. EBERHARDSON M, Hall S, Papp KA, Sterling TM, et al
    Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Clin Infect Dis. 2017;65:1174-1182.
    >> Share

  514. OLIGBU G, Collins S, Andrews N, Sheppard CL, et al
    Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Clin Infect Dis. 2017;65:1191-1198.
    >> Share

    September 2017
  515. SKOFF TH, Blain AE, Watt J, Scherzinger K, et al
    Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Clin Infect Dis. 2017 Sep 28. doi: 10.1093.
    >> Share

  516. LUCA DL, Kwong JC, Chu A, Sander B, et al
    Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  517. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  518. MADHI SA, Koen A, Cutland CL, Jose L, et al
    Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  519. ARCIUOLO RJ, Jablonski RR, Zucker JR, Rosen JB, et al
    Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    >> Share

  520. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    >> Share

  521. KIM L, Rha B, Abramson JS, Anderson LJ, et al
    Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
    Clin Infect Dis. 2017;65:1020-1025.
    >> Share

  522. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    >> Share

  523. GOGTAY NJ, Munshi R, Ashwathnarayan DH, Mahendra BJ, et al
    Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for post-exposure prophylaxis: A phase 2/3 randomized, single blind, non-inferiority, controlled study.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    >> Share

  524. MCNAMARA LA, Skoff T, Faulkner A, Miller L, et al
    Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.
    Clin Infect Dis. 2017;65:811-818.
    >> Share

  525. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Clin Infect Dis. 2017;65:787-795.
    >> Share

  526. PILLSBURY AJ, Quinn HE, Evans TD, McIntyre PB, et al
    Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
    Clin Infect Dis. 2017;65:827-832.
    >> Share

    August 2017
  527. YANG Y, Meng Y, Halloran ME, Longini IM Jr, et al
    Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  528. LEE YJ, Huang YT, Kim SJ, Kerpelev M, et al
    Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    >> Share

  529. SHAH M, Quinlisk P, Weigel A, Riley J, et al
    Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella (MMR) vaccination campaign-Iowa, July 2015-May 2016.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    >> Share

  530. HEATH G, Depledge DP, Brown JR, Hale AD, et al
    Acute Retinal Necrosis caused by the zoster vaccine virus.
    Clin Infect Dis. 2017 Aug 2. doi: 10.1093.
    >> Share

    July 2017
  531. LEWNARD JA, Givon-Lavi N, Weinberger DM, Lipsitch M, et al
    Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    >> Share

  532. WARREN JL, Shioda K, Kurum E, Schuck-Paim C, et al
    Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Clin Infect Dis. 2017 Jul 22. doi: 10.1093.
    >> Share

  533. PETRIE JG, Malosh RE, Cheng CK, Ohmit SE, et al
    The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    >> Share

    May 2017
  534. ZUCMAN D, Farfour E, Mazaux L, Hillaire S, et al
    How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines?
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    >> Share

  535. DE WALS P, Deceuninck G, Lefebvre B, Tsang R, et al
    Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    Clin Infect Dis. 2017;64:1263-1267.
    >> Share

    December 2016
  536. LARSON HJ
    Japanese media and the HPV vaccine saga.
    Clin Infect Dis. 2016.
    >> Share

  537. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    >> Share

    June 2016
  538. TRAN TT
    Hepatitis B in Pregnancy.
    Clin Infect Dis. 2016;62 Suppl 4:S314-7.
    >> Share

  539. SHANKAR H, Blanas D, Bichoupan K, Ndiaye D, et al
    A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.
    Clin Infect Dis. 2016;62 Suppl 4:S289-97.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016